Dual roles of p62/SQSTM1 in the injury and recovery phases of acetaminophen-induced liver injury in mice.
Dual roles of p62/SQSTM1 in the injury and recovery phases of acetaminophen-induced liver injury in mice.
复制标题
DOI:
10.1016/j.apsb.2021.11.010
复制
发表时间:
2021-12
期刊:
影响因子:
--
通讯作者:
Ding WX
中科院分区:
文献类型:
--
作者:
Qian H;Bai Q;Yang X;Akakpo JY;Ji L;Yang L;Rülicke T;Zatloukal K;Jaeschke H;Ni HM;Ding WX
Acetaminophen (APAP) overdose can induce liver injury and is the most frequent cause of acute liver failure in the United States. We investigated the role of p62/SQSTM1 (referred to as p62) in APAP-induced liver injury (AILI) in mice. We found that the hepatic protein levels of p62 dramatically increased at 24 h after APAP treatment, which was inversely correlated with the hepatic levels of APAP-adducts. APAP also activated mTOR at 24 h, which is associated with increased cell proliferation. In contrast, p62 knockout (KO) mice showed increased hepatic levels of APAP-adducts detected by a specific antibody using Western blot analysis but decreased mTOR activation and cell proliferation with aggravated liver injury at 24 h after APAP treatment. Surprisingly, p62 KO mice recovered from AILI whereas the wild-type mice still sustained liver injury at 48 h. We found increased number of infiltrated macrophages in p62 KO mice that were accompanied with decreased hepatic von Willebrand factor (VWF) and platelet aggregation, which are associated with increased cell proliferation and improved liver injury at 48 h after APAP treatment. Our data indicate that p62 inhibits the late injury phase of AILI by increasing autophagic selective removal of APAP-adducts and mitochondria but impairs the recovery phase of AILI likely by enhancing hepatic blood coagulation. p62 inhibits the late injury phase of acetaminophen-induced liver injury (AILI) by increasing autophagic selective removal of acetaminophen-adducts and mitochondria but impairs the recovery phase of AILI likely by enhancing hepatic blood coagulation.
登录
查看更多内容
影响因子:
2.8
作者:
Akakpo JY;Ramachandran A;Kandel SE;Ni HM;Kumer SC;Rumack BH;Jaeschke H
通讯作者:
Jaeschke H
DOI:
10.1056/nejmct0708278
发表时间:
2008-07-17
期刊:
The New England journal of medicine
影响因子:
--
作者:
Heard KJ
通讯作者:
Heard KJ
影响因子:
4.1
作者:
Ju, C;Reilly, TP;Pohl, LR
通讯作者:
Pohl, LR
影响因子:
4.8
作者:
Jain, Ashish;Lamark, Trond;Johansen, Terje
通讯作者:
Johansen, Terje
影响因子:
21.3
作者:
Komatsu, Masaaki;Kurokawa, Hirofumi;Yamamoto, Masayuki
通讯作者:
Yamamoto, Masayuki